🔎 Trials Near Me

Gara Jalqabaatti › Kansarii Pancreas › Oklahoma

Qorannoo klinikaalii Kansarii Pancreas Oklahoma keessatti

Qorannoo 12 Kansarii Pancreas f Oklahoma keessatti hirmaatuu jiru.

Magaalota Oklahoma keessatti

Takkalaa qorannoo (Ingiliffa)

The Vanguard Study: Testing a New Way to Screen for Cancer

  • University of Oklahoma Health Sciences Center, Oklahoma City
Namoota walitti qabaa jiraHojjettoota fayyaa simatamoo
Umuriin 45 hanga 75 · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT06995898

A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer

  • Mercy Hospital Oklahoma City - Mercy Coletta Cancer Center - Oklahoma City, Oklahoma City
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT07409272

Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors

  • Stephenson Cancer Center, Oklahoma City
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT06445062

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

  • University of Oklahoma, Oklahoma City
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT06128551

Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers

  • University of Oklahoma Health Sciences Center, Oklahoma City
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 50 hanga 75 · Saalaa hunda · Haaromfame 04-Ful-2026 · NCT04239573

A Study of DM002 in Patients With Advanced Solid Tumors

  • University of Oklahoma Health Sciences Center, Oklahoma City
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 07-Hag-2026 · NCT06751329

Testing A New Anti-cancer Drug Combination, Entinostat and ZEN003694, for Advanced and Refractory Solid Tumors

  • University of Oklahoma Health Sciences Center, Oklahoma City
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 15-Ado-2026 · NCT05053971

Safely Optimizing Body Weight With Mifomelatide (TCMCB07) in Patients With Newly Diagnosed Colorectal Cancer (CRC) or Pancreatic Ductal Adenocarcinoma (PDAC) Undergoing Chemotherapy

  • Hightower Clinical, Oklahoma City
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 15-Ado-2026 · NCT06937177

ctDNA Assay in Patients With Resectable Pancreatic Cancer

  • University of Oklahoma, Oklahoma City
  • Stephenson Cancer Center- Tulsa, Tulsa
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 hanga 99 · Saalaa hunda · Haaromfame 05-Bit-2026 · NCT05052671

A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations

  • Ohio State University-Telemedicine, Oklahoma City
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 17-Gur-2026 · NCT06906562

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

  • Massive Bio SYNERGY-AI site, Tulsa
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin hundi · Saalaa hunda · Haaromfame 28-Onk-2025 · NCT03452774

A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid Tumors

  • Exelixis Clinical Site #13, Oklahoma City
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 05-Ful-2025 · NCT05932862

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.